Olaratumab Completed Phase 1 Trials for Soft Tissue Sarcoma (STS) Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT02326025A Study of Olaratumab and Doxorubicin in Participants With Advanced Soft Tissue Sarcoma